Characterization and Quantification of Oxidized High Mobility Group Box 1 Proteoforms Secreted from Hepatocytes by Toxic Levels of Acetaminophen

The high mobility group box 1 (HMGB1), which is released during acute acetaminophen (APAP) overdose, is thought to mediate a subsequent immune response, particularly hepatic infiltration of macrophages. The redox behavior of HMGB1 and the proteoforms of HMGB1 present in oxidative environments has been the subject of a number of confusing and contradictory studies. Therefore, a stable isotope dilution two-dimensional nanoultrahigh-performance liquid chromatography parallel reaction monitoring/high-resolution mass spectrometry method was developed in order to characterize and quantify oxidative modifications to the cysteine (Cys) residues (Cys-23, Cys-45, and Cys-106) that are present in HMGB1. Disulfide linkages were determined using carbamidoethyl derivatization before and after reduction as well as by direct analysis of disulfide cross-linked peptides. A stable isotope labeled form of HMGB1 was used as an internal standard to correct for sample to sample differences in immunoaffinity precipitation, derivatization, and electrospray ionization. Four discrete HMGB1 proteoforms were found to be released from a hepatocarcinoma cell model of APAP overdose after 24 h. Fully reduced HMGB1 with all three Cys-residues in their free thiol state accounted for 18% of the secreted HMGB1. The proteoform with disulfide between Cys-23 and Cys-45 accounted for 24% of the HMGB1. No evidence was obtained for a disulfide cross-link between Cys-106 and the other two Cys-residues. However, 45% of the HMGB1 formed a cross-link with unidentified intracellular proteins via an intermolecular disulfide bond, and 12% was present as the terminally oxidized cysteic acid. Surprisingly, there was no evidence for the formation of HMGB1 disulfides with GSH or other low molecular weight thiols. Secreted plasma HMGB1 Cys-23/Cys45 disulfide proteoform together with the Cys-106/protein disulfide proteoforms could potentially serve as early biomarkers of hepatoxicity after APAP overdose as well as biomarkers of drug-induced liver injury.

[1]  D. Tang,et al.  The mechanism of HMGB1 secretion and release , 2022, Experimental & Molecular Medicine.

[2]  J. Wang,et al.  Platelet HMGB1 in Platelet-Rich Plasma (PRP) promotes tendon wound healing , 2021, PloS one.

[3]  R. Linhardt,et al.  Design of anti-inflammatory heparan sulfate to protect against acetaminophen-induced acute liver failure , 2020, Science Translational Medicine.

[4]  A. Tripathi,et al.  HMGB1 protein as a novel target for cancer , 2019, Toxicology reports.

[5]  R. Roy,et al.  Absolute quantitation of acetaminophen-modified human serum albumin in acute liver failure patients by LC-MS/MS. , 2018, Rapid communications in mass spectrometry : RCM.

[6]  Ian A Blair,et al.  Quantification of Serum High Mobility Group Box 1 by Liquid Chromatography/High-Resolution Mass Spectrometry: Implications for Its Role in Immunity, Inflammation, and Cancer , 2018, Analytical chemistry.

[7]  R. Pawlinski.  Platelet HMGB1: the venous clot coordinator. , 2016, Blood.

[8]  I. Shrivastava,et al.  Retracted: Redox‐dependent regulation of hepatocyte absent in melanoma 2 inflammasome activation in sterile liver injury in mice , 2016, Hepatology.

[9]  M. Lotze,et al.  Platelet-derived high-mobility group box 1 promotes recruitment and suppresses apoptosis of monocytes. , 2016, Biochemical and Biophysical Research Communications - BBRC.

[10]  Sheng‐yu Huang,et al.  Evaluation of disulfide scrambling during the enzymatic digestion of bevacizumab at various pH values using mass spectrometry. , 2016, Biochimica et biophysica acta.

[11]  M. Bianchi,et al.  HMGB1 as biomarker and drug target. , 2016, Pharmacological research.

[12]  U. Andersson,et al.  High Systemic Levels of the Cytokine-Inducing HMGB1 Isoform Secreted in Severe Macrophage Activation Syndrome , 2014, Molecular medicine.

[13]  R. Ben-Joseph,et al.  A perspective on the epidemiology of acetaminophen exposure and toxicity in the United States , 2014, Expert review of clinical pharmacology.

[14]  K. Tracey,et al.  A Systematic Nomenclature for the Redox States of High Mobility Group Box (HMGB) Proteins , 2014, Molecular medicine.

[15]  Mitchell R. McGill,et al.  Molecular forms of HMGB1 and keratin-18 as mechanistic biomarkers for mode of cell death and prognosis during clinical acetaminophen hepatotoxicity. , 2012, Journal of hepatology.

[16]  K. Tracey,et al.  Redox Modification of Cysteine Residues Regulates the Cytokine Activity of High Mobility Group Box-1 (HMGB1) , 2012, Molecular medicine.

[17]  L. Varani,et al.  HMGB1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with CXCL12 and signaling via CXCR4 , 2012, The Journal of experimental medicine.

[18]  Dominic P. Williams,et al.  Diet Restriction Inhibits Apoptosis and HMGB1 Oxidation and Promotes Inflammatory Cell Recruitment during Acetaminophen Hepatotoxicity , 2010, Molecular medicine.

[19]  U. Andersson,et al.  Immunomodulatory Drugs Regulate HMGB1 Release from Activated , 2010 .

[20]  N. Vermeulen,et al.  Liquid Chromatography/Tandem Mass Spectrometry Detection of Covalent Binding of Acetaminophen to Human Serum Albumin , 2007, Drug Metabolism and Disposition.

[21]  Haichao Wang,et al.  Hydrogen peroxide stimulates macrophages and monocytes to actively release HMGB1 , 2007, Journal of leukocyte biology.

[22]  M. Bianchi,et al.  The secretion of HMGB1 is required for the migration of maturing dendritic cells , 2007, Journal of leukocyte biology.

[23]  D. Pisetsky,et al.  The extracellular release of HMGB1 during apoptotic cell death. , 2006, American journal of physiology. Cell physiology.

[24]  K. Tracey,et al.  HMGB1 SIGNALS THROUGH TOLL-LIKE RECEPTOR (TLR) 4 AND TLR2 , 2006, Shock.

[25]  Kevin J. Tracey,et al.  High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal , 2005, Nature Reviews Immunology.

[26]  K. Tracey,et al.  Bacterial endotoxin stimulates macrophages to release HMGB1 partly through CD14‐ and TNF‐dependent mechanisms , 2004, Journal of leukocyte biology.

[27]  Tiziana Bonaldi,et al.  Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion , 2003, The EMBO journal.

[28]  T. Misteli,et al.  Release of chromatin protein HMGB1 by necrotic cells triggers inflammation , 2002, Nature.

[29]  S. Müller,et al.  The High Mobility Group (Hmg) Boxes of the Nuclear Protein Hmg1 Induce Chemotaxis and Cytoskeleton Reorganization in Rat Smooth Muscle Cells , 2001, The Journal of cell biology.

[30]  M. Schwab,et al.  Expression of Pro‐Inflammatory Cytokine and Chemokine mRNA Upon Experimental Spinal Cord Injury in Mouse: an In Situ Hybridization Study , 1997, The European journal of neuroscience.

[31]  J. Chen,et al.  The Receptor for Advanced Glycation End Products (RAGE) Is a Cellular Binding Site for Amphoterin , 1995, The Journal of Biological Chemistry.

[32]  Z. Hrkal,et al.  Differential expression of nuclear HMG1, HMG2 proteins and H10 histone in various blood cells , 1995, Cell biochemistry and function.

[33]  F. Guengerich,et al.  Cytochrome P450 enzymes involved in acetaminophen activation by rat and human liver microsomes and their kinetics. , 1993, Chemical research in toxicology.

[34]  K. Mori,et al.  Primary structure of non-histone protein HMG1 revealed by the nucleotide sequence. , 1988, Biochemistry.

[35]  J. Clements,et al.  Clinical Pharmacokinetics of Paracetamol , 1982, Clinical pharmacokinetics.

[36]  G. Koch,et al.  Acetaminophen overdose. 662 cases with evaluation of oral acetylcysteine treatment. , 1981 .

[37]  K. Ham,et al.  Studies on the mechanism of toxicity of acetaminophen. Synthesis and reactions of N-acetyl-2,6-dimethyl- and N-acetyl-3,5-dimethyl-p-benzoquinone imines. , 1980, Journal of medicinal chemistry.

[38]  Y. Burstein,et al.  Selective oxidation of methionine residues in proteins. , 1975, Biochemistry.

[39]  Seon-Hwa Lee,et al.  LC-MS analyses of N-acetyl-p-benzoquinone imine-adducts of glutathione, cysteine, N-acetylcysteine, and albumin in a plasma sample: A case study from a patient with a rare acetaminophen-induced acute swelling rash. , 2019, The Journal of toxicological sciences.